James H. Woods - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
behavioral pharmacology

365 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Winger G, Jutkiewicz EM, Woods JH. Comparison of the muscarinic antagonist effects of scopolamine and L-687,306. Behavioural Pharmacology. PMID 31922966 DOI: 10.1097/Fbp.0000000000000537  0.635
2020 Smith HR, Zamora JC, Chavera TS, Jennings EM, Winger GD, Woods JH, Clarke WP, Berg KA. Agonist‐Dependent Modulation by the Long‐Acting Mu Opioid Receptor Antagonist, Methocinnamox (MCAM) The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.06832  0.424
2019 Zamora JC, Kotipalli V, Jennings EM, Disney A, Husbands S, Winger G, Clarke WP, Woods JH, Berg KA. Methocinnamox (MCAM) is a Selective, Long Acting Antagonist at Mu Opioid Receptors In Vitro The Faseb Journal. 33. DOI: 10.1096/Fasebj.2019.33.1_Supplement.498.8  0.427
2018 Gerak LR, Maguire DR, Woods JH, Husbands SM, Disney A, France CP. Reversal and prevention of the respiratory-depressant effects of heroin by the novel µ opioid receptor antagonist methocinnamox in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. PMID 30463875 DOI: 10.1124/Jpet.118.253286  0.757
2018 Maguire DR, Gerak LR, Woods JH, Husbands SM, Disney A, France CP. Long-lasting effects of methocinnamox on heroin self-administration in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. PMID 30401680 DOI: 10.1124/Jpet.118.252353  0.79
2016 Saccone PA, Lindsey AM, Koeppe RA, Zelenock KA, Shao X, Sherman P, Quesada CA, Woods JH, Scott PJ. Intranasal opioid administration in rhesus monkeys: PET imaging and antinociception. The Journal of Pharmacology and Experimental Therapeutics. PMID 27625351 DOI: 10.1124/Jpet.116.235192  0.454
2016 Saccone PA, Zelenock KA, Linsdey AM, Sulima A, Rice KC, Prinssen EP, Wichmann J, Woods JH. Characterization of the discriminative stimulus effects of a NOP receptor agonist Ro 64-6198 in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. PMID 26801398 DOI: 10.1124/Jpet.115.231134  0.346
2015 Bertz JW, Jackson EL, Barron DR, Woods JH. Effects of sex and remifentanil dose on rats' acquisition of responding for a remifentanil-conditioned reinforcer. Behavioural Pharmacology. PMID 26580131 DOI: 10.1097/FBP.0000000000000205  0.411
2015 Bertz JW, Chen J, Woods JH. Effects of pramipexole on the acquisition of responding with opioid-conditioned reinforcement in the rat. Psychopharmacology. 232: 209-21. PMID 24985891 DOI: 10.1007/s00213-014-3659-2  0.303
2015 Saccone PA, Zelenock KA, Lindsey A, Zaks ME, Woods JH. Characterization of the discriminative stimulus effects of the NOP agonist Ro 64-6198 in non-human primates Drug and Alcohol Dependence. 146. DOI: 10.1016/J.Drugalcdep.2014.09.603  0.33
2015 Bertz JW, Woods JH. Effects of sex and remifentanil dose on the acquisition of responding for a remifentanil-associated stimulus Drug and Alcohol Dependence. 146. DOI: 10.1016/J.Drugalcdep.2014.09.074  0.313
2014 Howell L, Nye J, Stehouwer J, Voll R, Mun J, Narasimhan D, Nichols J, Sunahara R, Goodman M, Carroll F, Woods J. Effects of a mutant bacterial cocaine esterase on cocaine brain levels measured with pet neuroimaging in rhesus monkeys Drug and Alcohol Dependence. 140: e92-e93. DOI: 10.1016/J.Drugalcdep.2014.02.269  0.386
2013 Kishioka S, Kiguchi N, Kobayashi Y, Yamamoto C, Saika F, Wakida N, Ko MC, Woods JH. Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice. Neuroscience Letters. 552: 98-102. PMID 23933210 DOI: 10.1016/j.neulet.2013.07.040  0.362
2013 Bertz JW, Woods JH. Acquisition of responding with a remifentanil-associated conditioned reinforcer in the rat. Psychopharmacology. 229: 235-43. PMID 23609770 DOI: 10.1007/s00213-013-3102-0  0.376
2013 Jutkiewicz EM, Rice KC, Carroll FI, Woods JH. Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats. Drug and Alcohol Dependence. 131: 284-97. PMID 23333294 DOI: 10.1016/J.Drugalcdep.2012.12.021  0.628
2013 Koffarnus MN, Woods JH. Individual differences in discount rate are associated with demand for self-administered cocaine, but not sucrose. Addiction Biology. 18: 8-18. PMID 21812874 DOI: 10.1111/J.1369-1600.2011.00361.X  0.685
2012 Moynihan HA, Derrick I, Broadbear JH, Greedy BM, Aceto MD, Harris LS, Purington LC, Thomas MP, Woods JH, Traynor JR, Husbands SM, Lewis JW. Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effects. Journal of Medicinal Chemistry. 55: 9868-74. PMID 23043264 DOI: 10.1021/jm301096s  0.4
2012 Koffarnus MN, Collins GT, Rice KC, Chen J, Woods JH, Winger G. Self-administration of agonists selective for dopamine D2, D3, and D4 receptors by rhesus monkeys. Behavioural Pharmacology. 23: 331-8. PMID 22785383 DOI: 10.1097/Fbp.0B013E3283564Dbb  0.777
2012 Collins GT, Brim RL, Noon KR, Narasimhan D, Lukacs NW, Sunahara RK, Woods JH, Ko MC. Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 342: 205-13. PMID 22518021 DOI: 10.1124/Jpet.112.194639  0.815
2012 Lee TY, Park YS, Garcia GA, Sunahara RK, Woods JH, Yang VC. Cell permeable cocaine esterases constructed by chemical conjugation and genetic recombination. Molecular Pharmaceutics. 9: 1361-73. PMID 22404344 DOI: 10.1021/Mp200623W  0.379
2012 Narasimhan D, Woods JH, Sunahara RK. Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction. Future Medicinal Chemistry. 4: 137-50. PMID 22300094 DOI: 10.4155/Fmc.11.194  0.404
2012 Collins GT, Narasimhan D, Cunningham AR, Zaks ME, Nichols J, Ko MC, Sunahara RK, Woods JH. Long-lasting effects of a PEGylated mutant cocaine esterase (CocE) on the reinforcing and discriminative stimulus effects of cocaine in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1092-103. PMID 21993206 DOI: 10.1038/Npp.2011.226  0.69
2012 Brim RL, Noon KR, Collins GT, Stein A, Nichols J, Narasimhan D, Ko MC, Woods JH, Sunahara RK. The fate of bacterial cocaine esterase (CocE): an in vivo study of CocE-mediated cocaine hydrolysis, CocE pharmacokinetics, and CocE elimination. The Journal of Pharmacology and Experimental Therapeutics. 340: 83-95. PMID 21990608 DOI: 10.1124/Jpet.111.186049  0.819
2012 Collins GT, Cunningham AR, Chen J, Wang S, Newman AH, Woods JH. Effects of pramipexole on the reinforcing effectiveness of stimuli that were previously paired with cocaine reinforcement in rats. Psychopharmacology. 219: 123-35. PMID 21701814 DOI: 10.1007/S00213-011-2382-5  0.698
2011 Chen J, Collins GT, Levant B, Woods J, Deschamps JR, Wang S. CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist. Acs Medicinal Chemistry Letters. 2: 620-625. PMID 22125662 DOI: 10.1021/Ml200100T  0.623
2011 Jimenez-Gomez C, Osentoski A, Woods JH. Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety. Behavioural Pharmacology. 22: 711-3. PMID 21921841 DOI: 10.1097/Fbp.0B013E32834Afebe  0.726
2011 Narasimhan D, Collins GT, Nance MR, Nichols J, Edwald E, Chan J, Ko MC, Woods JH, Tesmer JJ, Sunahara RK. Subunit stabilization and polyethylene glycolation of cocaine esterase improves in vivo residence time. Molecular Pharmacology. 80: 1056-65. PMID 21890748 DOI: 10.1124/Mol.111.074997  0.655
2011 Brim RL, Noon KR, Collins GT, Nichols J, Narasimhan D, Sunahara RK, Woods JH. The ability of bacterial cocaine esterase to hydrolyze cocaine metabolites and their simultaneous quantification using high-performance liquid chromatography-tandem mass spectrometry. Molecular Pharmacology. 80: 1119-27. PMID 21885621 DOI: 10.1124/Mol.111.074534  0.812
2011 Brim RL, Noon KR, Nichols J, Narasimhan D, Woods JH, Sunahara RK. Evaluation of the hydrolytic activity of a long-acting mutant bacterial cocaine in the presence of commonly co-administered drugs. Drug and Alcohol Dependence. 119: 224-8. PMID 21775073 DOI: 10.1016/J.Drugalcdep.2011.06.018  0.824
2011 Jutkiewicz EM, Brooks EA, Kynaston AD, Rice KC, Woods JH. Patterns of nicotinic receptor antagonism: nicotine discrimination studies. The Journal of Pharmacology and Experimental Therapeutics. 339: 194-202. PMID 21730011 DOI: 10.1124/Jpet.111.182170  0.643
2011 Koffarnus MN, Newman AH, Grundt P, Rice KC, Woods JH. Effects of selective dopaminergic compounds on a delay-discounting task. Behavioural Pharmacology. 22: 300-11. PMID 21694584 DOI: 10.1097/Fbp.0B013E3283473Bcb  0.674
2011 Collins GT, Zaks ME, Cunningham AR, St Clair C, Nichols J, Narasimhan D, Ko MC, Sunahara RK, Woods JH. Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats. Drug and Alcohol Dependence. 118: 158-65. PMID 21481548 DOI: 10.1016/J.Drugalcdep.2011.03.015  0.689
2011 Collins GT, Carey KA, Narasimhan D, Nichols J, Berlin AA, Lukacs NW, Sunahara RK, Woods JH, Ko MC. Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1047-59. PMID 21289605 DOI: 10.1038/Npp.2010.242  0.691
2011 Collins GT, Truong YN, Levant B, Chen J, Wang S, Woods JH. Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity. Psychopharmacology. 215: 609-20. PMID 21207013 DOI: 10.1007/S00213-010-2154-7  0.65
2011 Jimenez-Gomez C, Winger G, Dean RL, Deaver DR, Woods JH. Naltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys. Behavioural Pharmacology. 22: 87-90. PMID 21160425 DOI: 10.1097/Fbp.0B013E3283423D55  0.777
2011 Xue L, Ko MC, Tong M, Yang W, Hou S, Fang L, Liu J, Zheng F, Woods JH, Tai HH, Zhan CG. Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine. Molecular Pharmacology. 79: 290-7. PMID 20971807 DOI: 10.1124/mol.110.068494  0.43
2011 Podlesnik CA, Ko MC, Winger G, Wichmann J, Prinssen EP, Woods JH. The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys. Psychopharmacology. 213: 53-60. PMID 20852848 DOI: 10.1007/S00213-010-2012-7  0.724
2011 Bergman J, Woods JH. Charles Roberts Schuster Neuropsychopharmacology. 36: 2782-2782. DOI: 10.1038/Npp.2011.71  0.315
2011 Koek W, Woods JH, France CP. Obituary: Francis C. Colpaert, Ph.D. (1950-2010) Psychopharmacology. 1-2. DOI: 10.1007/S00213-011-2179-6  0.46
2010 Pichika R, Jewett DM, Sherman PS, Traynor JR, Husbands SM, Woods JH, Kilbourn MR. Synthesis and in vivo brain distribution of carbon-11-labeled δ-opioid receptor agonists. Nuclear Medicine and Biology. 37: 989-96. PMID 21055630 DOI: 10.1016/J.Nucmedbio.2010.06.002  0.577
2010 Podlesnik CA, Jimenez-Gomez C, Woods JH. A choice procedure to assess the aversive effects of drugs in rodents. Journal of the Experimental Analysis of Behavior. 93: 203-23. PMID 20885811 DOI: 10.1901/Jeab.2010.93-203  0.807
2010 Fantegrossi WE, Simoneau J, Cohen MS, Zimmerman SM, Henson CM, Rice KC, Woods JH. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice. The Journal of Pharmacology and Experimental Therapeutics. 335: 728-34. PMID 20858706 DOI: 10.1124/Jpet.110.172247  0.638
2010 Cooper ZD, Shi YG, Woods JH. Reinforcer-dependent enhancement of operant responding in opioid-withdrawn rats. Psychopharmacology. 212: 369-78. PMID 20686752 DOI: 10.1007/S00213-010-1966-9  0.725
2010 Li SM, Collins GT, Paul NM, Grundt P, Newman AH, Xu M, Grandy DK, Woods JH, Katz JL. Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats. Behavioural Pharmacology. 21: 171-81. PMID 20463460 DOI: 10.1097/Fbp.0B013E32833A5C68  0.625
2010 Narasimhan D, Nance MR, Gao D, Ko MC, Macdonald J, Tamburi P, Yoon D, Landry DM, Woods JH, Zhan CG, Tesmer JJ, Sunahara RK. Structural analysis of thermostabilizing mutations of cocaine esterase. Protein Engineering, Design & Selection : Peds. 23: 537-47. PMID 20436035 DOI: 10.1093/Protein/Gzq025  0.414
2010 Brim RL, Nance MR, Youngstrom DW, Narasimhan D, Zhan CG, Tesmer JJ, Sunahara RK, Woods JH. A thermally stable form of bacterial cocaine esterase: a potential therapeutic agent for treatment of cocaine abuse. Molecular Pharmacology. 77: 593-600. PMID 20086035 DOI: 10.1124/Mol.109.060806  0.815
2010 Park JB, Kwon YM, Lee TY, Brim R, Ko MC, Sunahara RK, Woods JH, Yang VC. PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicity. Journal of Controlled Release : Official Journal of the Controlled Release Society. 142: 174-9. PMID 19857534 DOI: 10.1016/J.Jconrel.2009.10.015  0.811
2010 Wood SK, Narasimhan D, Cooper Z, Sunahara RK, Woods JH. Prevention and reversal by cocaine esterase of cocaine-induced cardiovascular effects in rats. Drug and Alcohol Dependence. 106: 219-29. PMID 19800183 DOI: 10.1016/J.Drugalcdep.2009.09.001  0.768
2010 Jutkiewicz EM, Baladi MG, Cooper ZD, Woods JH. In reply Annals of Emergency Medicine. 55: 485-486. DOI: 10.1016/j.annemergmed.2009.11.028  0.742
2009 Nieland NP, Rennison D, Broadbear JH, Purington L, Woods JH, Traynor JR, Lewis JW, Husbands SM. 14beta-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and related opioids. Further examples of pseudoirreversible mu opioid receptor antagonists. Journal of Medicinal Chemistry. 52: 6926-30. PMID 19842669 DOI: 10.1021/Jm901074A  0.36
2009 Collins GT, Brim RL, Narasimhan D, Ko MC, Sunahara RK, Zhan CG, Woods JH. Cocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats. The Journal of Pharmacology and Experimental Therapeutics. 331: 445-55. PMID 19710369 DOI: 10.1124/Jpet.108.150029  0.826
2009 Collins GT, Woods JH. Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats. Behavioural Pharmacology. 20: 492-504. PMID 19696656 DOI: 10.1097/Fbp.0B013E328330Ad9B  0.687
2009 Ko MC, Woods JH, Fantegrossi WE, Galuska CM, Wichmann J, Prinssen EP. Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2088-96. PMID 19279568 DOI: 10.1038/npp.2009.33  0.722
2009 Moynihan H, Jales AR, Greedy BM, Rennison D, Broadbear JH, Purington L, Traynor JR, Woods JH, Lewis JW, Husbands SM. 14 beta-O-cinnamoylnaltrexone and related dihydrocodeinones are mu opioid receptor partial agonists with predominant antagonist activity. Journal of Medicinal Chemistry. 52: 1553-7. PMID 19253983 DOI: 10.1021/Jm8012272  0.422
2009 Ko MC, Narasimhan D, Berlin AA, Lukacs NW, Sunahara RK, Woods JH. Effects of cocaine esterase following its repeated administration with cocaine in mice. Drug and Alcohol Dependence. 101: 202-9. PMID 19217723 DOI: 10.1016/J.Drugalcdep.2009.01.002  0.455
2009 Collins GT, Truccone A, Haji-Abdi F, Newman AH, Grundt P, Rice KC, Husbands SM, Greedy BM, Enguehard-Gueiffier C, Gueiffier A, Chen J, Wang S, Katz JL, Grandy DK, Sunahara RK, ... Woods JH, et al. Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice. The Journal of Pharmacology and Experimental Therapeutics. 329: 210-7. PMID 19136638 DOI: 10.1124/Jpet.108.144048  0.622
2009 Jutkiewicz EM, Baladi MG, Cooper ZD, Narasimhan D, Sunahara RK, Woods JH. A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality. Annals of Emergency Medicine. 54: 409-20. PMID 19013687 DOI: 10.1016/J.Annemergmed.2008.09.023  0.814
2009 Gao D, Narasimhan DL, Macdonald J, Brim R, Ko MC, Landry DW, Woods JH, Sunahara RK, Zhan CG. Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Molecular Pharmacology. 75: 318-23. PMID 18987161 DOI: 10.1124/Mol.108.049486  0.809
2009 Koffarnus MN, Greedy B, Husbands SM, Grundt P, Newman AH, Woods JH. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats. Psychopharmacology. 203: 317-27. PMID 18807248 DOI: 10.1007/S00213-008-1323-4  0.686
2008 Collins GT, Woods JH. Narrowing in on compulsions: dopamine receptor functions. Experimental and Clinical Psychopharmacology. 16: 498-502. PMID 19086770 DOI: 10.1037/A0014190  0.661
2008 Chen J, Collins GT, Zhang J, Yang CY, Levant B, Woods J, Wang S. Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile. Journal of Medicinal Chemistry. 51: 5905-8. PMID 18785726 DOI: 10.1021/Jm800471H  0.616
2008 Zheng F, Yang W, Ko MC, Liu J, Cho H, Gao D, Tong M, Tai HH, Woods JH, Zhan CG. Most efficient cocaine hydrolase designed by virtual screening of transition states. Journal of the American Chemical Society. 130: 12148-55. PMID 18710224 DOI: 10.1021/ja803646t  0.374
2008 Cooper ZD, Truong YN, Shi YG, Woods JH. Morphine deprivation increases self-administration of the fast- and short-acting mu-opioid receptor agonist remifentanil in the rat. The Journal of Pharmacology and Experimental Therapeutics. 326: 920-9. PMID 18515643 DOI: 10.1124/Jpet.108.139196  0.715
2008 Xie H, Woods JH, Traynor JR, Ko MC. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies. Anesthesia and Analgesia. 106: 1873-81. PMID 18499626 DOI: 10.1213/ane.0b013e31817300be  0.41
2008 Koffarnus MN, Woods JH. Quantification of drug choice with the generalized matching law in rhesus monkeys. Journal of the Experimental Analysis of Behavior. 89: 209-24. PMID 18422019 DOI: 10.1901/Jeab.2008.89-209  0.68
2008 Pascoe JE, Williams KL, Mukhopadhyay P, Rice KC, Woods JH, Ko MC. Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys. Psychoneuroendocrinology. 33: 478-86. PMID 18325678 DOI: 10.1016/J.Psyneuen.2008.01.006  0.48
2008 Collins GT, Calinski DM, Newman AH, Grundt P, Woods JH. Food restriction alters N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effects. The Journal of Pharmacology and Experimental Therapeutics. 325: 691-7. PMID 18305018 DOI: 10.1124/Jpet.107.133181  0.648
2008 Fantegrossi WE, Ciullo JR, Wakabayashi KT, De La Garza R, Traynor JR, Woods JH. A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse. Neuroscience. 151: 533-43. PMID 18082974 DOI: 10.1016/J.Neuroscience.2007.11.007  0.8
2008 Jutkiewicz EM, Baladi MG, Folk JE, Rice KC, Woods JH. The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats. The Journal of Pharmacology and Experimental Therapeutics. 324: 714-24. PMID 17986650 DOI: 10.1124/Jpet.107.123844  0.825
2008 Metcalf MD, Aceto MD, Harris LS, Woods JH, Traynor JR, Coop A, May EL. The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans. Bioorganic & Medicinal Chemistry. 16: 869-73. PMID 17962026 DOI: 10.1016/j.bmc.2007.10.030  0.354
2008 Kilbourn MR, Donnelly D, Husbands S, Greedy B, Woods J, Traynor J. Synthesis and in vivo PET imaging studies with [11C]BU4033, a potential delta opioid imaging agent Neuroimage. 41: T23. DOI: 10.1016/J.Neuroimage.2008.04.197  0.521
2007 Wood SK, Woods JH. Corticotropin-releasing factor receptor-1: a therapeutic target for cardiac autonomic disturbances. Expert Opinion On Therapeutic Targets. 11: 1401-13. PMID 18028006 DOI: 10.1517/14728222.11.11.1401  0.586
2007 Chadman KK, Woods JH, Stitzel J. Chlorisondamine inhibits the nicotine-induced stimulation of c-fos in the pigeon brain for up to 2 weeks. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 927-36. PMID 17763108 DOI: 10.1080/14622200701540838  0.696
2007 Lee H, Naughton NN, Woods JH, Ko MC. Effects of butorphanol on morphine-induced itch and analgesia in primates. Anesthesiology. 107: 478-85. PMID 17721251 DOI: 10.1097/01.anes.0000278876.20263.a7  0.492
2007 Collins GT, Woods JH. Drug and reinforcement history as determinants of the response-maintaining effects of quinpirole in the rat. The Journal of Pharmacology and Experimental Therapeutics. 323: 599-605. PMID 17675585 DOI: 10.1124/Jpet.107.123042  0.647
2007 Wade-Galuska T, Winger G, Woods JH. A behavioral economic analysis of cocaine and remifentanil self-administration in rhesus monkeys. Psychopharmacology. 194: 563-72. PMID 17628791 DOI: 10.1007/s00213-007-0858-0  0.358
2007 Zhang H, Shi YG, Woods JH, Watson SJ, Ko MC. Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies. European Journal of Pharmacology. 570: 89-96. PMID 17601558 DOI: 10.1016/j.ejphar.2007.05.045  0.443
2007 Collins GT, Newman AH, Grundt P, Rice KC, Husbands SM, Chauvignac C, Chen J, Wang S, Woods JH. Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists. Psychopharmacology. 193: 159-70. PMID 17393143 DOI: 10.1007/S00213-007-0766-3  0.622
2007 Galuska CM, Wade-Galuska T, Woods JH, Winger G. Fixed-ratio schedules of cocaine self-administration in rhesus monkeys: joint control of responding by past and upcoming doses. Behavioural Pharmacology. 18: 171-5. PMID 17351424 DOI: 10.1097/FBP.0b013e3280d48073  0.407
2007 Ko MC, Bowen LD, Narasimhan D, Berlin AA, Lukacs NW, Sunahara RK, Cooper ZD, Woods JH. Cocaine esterase: interactions with cocaine and immune responses in mice. The Journal of Pharmacology and Experimental Therapeutics. 320: 926-33. PMID 17114567 DOI: 10.1124/Jpet.106.114223  0.687
2007 Jutkiewicz EM, DenBesten N, Carroll FI, Woods JH. Depressant‐like effects of delta‐opioid receptor blockade in the forced swim test in rats The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A411-B  0.625
2006 Galuska CM, Winger G, Hursh SR, Woods JH. Assessing unit-price related remifentanil choice in rhesus monkeys. Journal of the Experimental Analysis of Behavior. 86: 181-95. PMID 17002226 DOI: 10.1901/jeab.2006.108.05  0.331
2006 Cooper ZD, Narasimhan D, Sunahara RK, Mierzejewski P, Jutkiewicz EM, Larsen NA, Wilson IA, Landry DW, Woods JH. Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase. Molecular Pharmacology. 70: 1885-91. PMID 16968810 DOI: 10.1124/Mol.106.025999  0.784
2006 Nieland NP, Moynihan HA, Carrington S, Broadbear J, Woods JH, Traynor JR, Husbands SM, Lewis JW. Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinones. Journal of Medicinal Chemistry. 49: 5333-8. PMID 16913723 DOI: 10.1021/jm0604777  0.361
2006 Ko MC, Wei H, Woods JH, Kennedy RT. Effects of intrathecally administered nociceptin/orphanin FQ in monkeys: behavioral and mass spectrometric studies. The Journal of Pharmacology and Experimental Therapeutics. 318: 1257-64. PMID 16766718 DOI: 10.1124/Jpet.106.106120  0.345
2006 Wood SK, Verhoeven RE, Savit AZ, Rice KC, Fischbach PS, Woods JH. Facilitation of cardiac vagal activity by CRF-R1 antagonists during swim stress in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2580-90. PMID 16710322 DOI: 10.1038/Sj.Npp.1301085  0.624
2006 Winger G, Galuska CM, Hursh SR, Woods JH. Relative reinforcing effects of cocaine, remifentanil, and their combination in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 318: 223-9. PMID 16571623 DOI: 10.1124/jpet.105.100461  0.408
2006 Jutkiewicz EM, Baladi MG, Folk JE, Rice KC, Woods JH. The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol. The Journal of Pharmacology and Experimental Therapeutics. 317: 1337-48. PMID 16537798 DOI: 10.1124/Jpet.105.095810  0.822
2006 Zhang H, Torregrossa MM, Jutkiewicz EM, Shi YG, Rice KC, Woods JH, Watson SJ, Ko MC. Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects. The European Journal of Neuroscience. 23: 984-94. PMID 16519663 DOI: 10.1111/J.1460-9568.2006.04621.X  0.78
2006 Fantegrossi WE, Harrington AW, Kiessel CL, Eckler JR, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH. Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats. Pharmacology, Biochemistry, and Behavior. 83: 122-9. PMID 16460788 DOI: 10.1016/J.Pbb.2005.12.015  0.623
2006 Jutkiewicz EM, Torregrossa MM, Sobczyk-Kojiro K, Mosberg HI, Folk JE, Rice KC, Watson SJ, Woods JH. Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects. European Journal of Pharmacology. 531: 151-9. PMID 16442521 DOI: 10.1016/J.Ejphar.2005.12.002  0.8
2006 Torregrossa MM, Jutkiewicz EM, Mosberg HI, Balboni G, Watson SJ, Woods JH. Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats. Brain Research. 1069: 172-81. PMID 16364263 DOI: 10.1016/J.Brainres.2005.11.005  0.772
2006 Ko MC, Divin MF, Lee H, Woods JH, Traynor JR. Differential in vivo potencies of naltrexone and 6beta-naltrexol in the monkey. The Journal of Pharmacology and Experimental Therapeutics. 316: 772-9. PMID 16258020 DOI: 10.1124/Jpet.105.094409  0.389
2005 Fantegrossi WE, Kugle KM, Valdes LJ, Koreeda M, Woods JH. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse. Behavioural Pharmacology. 16: 627-33. PMID 16286814 DOI: 10.1097/00008877-200512000-00005  0.703
2005 Galuska CM, Woods JH. Acquisition of cocaine self-administration with unsignaled delayed reinforcement in rhesus monkeys. Journal of the Experimental Analysis of Behavior. 84: 269-80. PMID 16262189 DOI: 10.1901/jeab.2005.99-04  0.433
2005 Torregrossa MM, Folk JE, Rice KC, Watson SJ, Woods JH. Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats. Psychopharmacology. 183: 31-40. PMID 16220339 DOI: 10.1007/S00213-005-0113-5  0.642
2005 Jutkiewicz EM, Rice KC, Traynor JR, Woods JH. Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats. Psychopharmacology. 182: 588-96. PMID 16163520 DOI: 10.1007/S00213-005-0138-9  0.724
2005 Cook JB, Foster KL, Eiler WJ, McKay PF, Woods J, Harvey SC, Garcia M, Grey C, McCane S, Mason D, Cummings R, Li X, Cook JM, June HL. Selective GABAA alpha5 benzodiazepine inverse agonist antagonizes the neurobehavioral actions of alcohol. Alcoholism, Clinical and Experimental Research. 29: 1390-401. PMID 16131846 DOI: 10.1097/01.Alc.0000175073.94575.86  0.335
2005 Jutkiewicz EM, Kaminsky ST, Rice KC, Traynor JR, Woods JH. Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats. The Journal of Pharmacology and Experimental Therapeutics. 315: 414-22. PMID 16014751 DOI: 10.1124/Jpet.105.088831  0.718
2005 Fantegrossi WE, Kiessel CL, De la Garza R, Woods JH. Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse. Psychopharmacology. 181: 529-36. PMID 15983787 DOI: 10.1007/s00213-005-0005-8  0.623
2005 Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats. Psychopharmacology. 181: 496-503. PMID 15983786 DOI: 10.1007/S00213-005-0009-4  0.631
2005 Collins GT, Witkin JM, Newman AH, Svensson KA, Grundt P, Cao J, Woods JH. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior. The Journal of Pharmacology and Experimental Therapeutics. 314: 310-9. PMID 15833897 DOI: 10.1124/Jpet.105.085472  0.626
2005 Husbands SM, Neilan CL, Broadbear J, Grundt P, Breeden S, Aceto MD, Woods JH, Lewis JW, Traynor JR. BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism. European Journal of Pharmacology. 509: 117-25. PMID 15733546 DOI: 10.1016/j.ejphar.2004.12.035  0.462
2005 Jutkiewicz EM, Wood SK, Houshyar H, Hsin LW, Rice KC, Woods JH. The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats. Psychopharmacology. 180: 215-23. PMID 15696320 DOI: 10.1007/S00213-005-2164-Z  0.791
2005 Fantegrossi WE, Ko MC, Woods JH, Richelson E. Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys. Pharmacology, Biochemistry, and Behavior. 80: 341-9. PMID 15680187 DOI: 10.1016/j.pbb.2004.12.005  0.701
2005 Fantegrossi WE, Winger G, Woods JH, Woolverton WL, Coop A. Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys. Drug and Alcohol Dependence. 77: 161-8. PMID 15664717 DOI: 10.1016/J.Drugalcdep.2004.07.014  0.695
2005 Jutkiewicz EM, Walker NP, Folk JE, Rice KC, Portoghese PS, Woods JH, Traynor JR. Comparison of peptidic and nonpeptidic delta-opioid agonists on guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding in brain slices from Sprague-Dawley rats. The Journal of Pharmacology and Experimental Therapeutics. 312: 1314-20. PMID 15574687 DOI: 10.1124/Jpet.104.078741  0.69
2005 Broadbear JH, Winger G, Woods JH. Self-administration of methohexital, midazolam and ethanol: effects on the pituitary-adrenal axis in rhesus monkeys. Psychopharmacology. 178: 83-91. PMID 15322724 DOI: 10.1007/s00213-004-1986-4  0.386
2004 Parrott AC, Fantegrossi WE, Woods JH, Winger G, Kilbourn M, Sherman P, Woolverton WL, Yuan J, Hatzidimitriou G, Ricaurte GA. MDMA and the loss of reinforcement in Fantegrossi et al (2004) (multiple letters) Neuropsychopharmacology. 29: 1940-1942. PMID 15383828 DOI: 10.1038/Sj.Npp.1300538  0.65
2004 Neilan CL, Husbands SM, Breeden S, Ko MC, Aceto MD, Lewis JW, Woods JH, Traynor JR. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist. European Journal of Pharmacology. 499: 107-16. PMID 15363957 DOI: 10.1016/j.ejphar.2004.07.097  0.454
2004 Broadbear JH, Winger G, Woods JH. Self-administration of fentanyl, cocaine and ketamine: effects on the pituitary-adrenal axis in rhesus monkeys. Psychopharmacology. 176: 398-406. PMID 15114434 DOI: 10.1007/s00213-004-1891-x  0.493
2004 Williams KL, Broadbear JH, Woods JH. Noncontingent and response-contingent intravenous ethanol attenuates the effect of naltrexone on hypothalamic-pituitary-adrenal activity in rhesus monkeys. Alcoholism, Clinical and Experimental Research. 28: 566-71. PMID 15100607 DOI: 10.1097/01.ALC.0000121655.48922.C4  0.322
2004 Fantegrossi WE, Woods JH, Winger G. Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys. Behavioural Pharmacology. 15: 149-57. PMID 15096915 DOI: 10.1097/00008877-200403000-00007  0.661
2004 Mendelson WB, Roth T, Cassella J, Roehrs T, Walsh JK, Woods JH, Buysse DJ, Meyer RE. The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. Sleep Medicine Reviews. 8: 7-17. PMID 15062207 DOI: 10.1016/S1087-0792(03)00042-X  0.311
2004 Fantegrossi WE, Woolverton WL, Kilbourn M, Sherman P, Yuan J, Hatzidimitriou G, Ricaurte GA, Woods JH, Winger G. Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1270-81. PMID 15039771 DOI: 10.1038/Sj.Npp.1300442  0.743
2004 Broadbear JH, Winger G, Rivier JE, Rice KC, Woods JH. Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1112-21. PMID 14997174 DOI: 10.1038/Sj.Npp.1300410  0.389
2004 Fantegrossi WE, Kiessel CL, Leach PT, Van Martin C, Karabenick RL, Chen X, Ohizumi Y, Ullrich T, Rice KC, Woods JH. Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice. Psychopharmacology. 173: 270-7. PMID 14740148 DOI: 10.1007/S00213-003-1741-2  0.676
2004 Jutkiewicz EM, Eller EB, Folk JE, Rice KC, Traynor JR, Woods JH. Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats. The Journal of Pharmacology and Experimental Therapeutics. 309: 173-81. PMID 14722329 DOI: 10.1124/Jpet.103.061242  0.68
2004 Torregrossa MM, Isgor C, Folk JE, Rice KC, Watson SJ, Woods JH. The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 649-59. PMID 14647482 DOI: 10.1038/Sj.Npp.1300345  0.654
2004 Chadman KK, Woods JH. Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon. The Journal of Pharmacology and Experimental Therapeutics. 308: 73-8. PMID 14566012 DOI: 10.1124/Jpet.103.057307  0.71
2004 Fantegrossi WE, Woods JH, Winger G, Kilbourn M, Sherman P, Woolverton WL, Yuan J, Hatzidimitriou G, Ricaurte GA. Reply: MDMA and the Loss of Reinforcement in Fantegrossi et al (2004) Neuropsychopharmacology. 29: 1942-1942. DOI: 10.1038/Sj.Npp.1300539  0.65
2003 Jutkiewicz EM, Rice KC, Woods JH, Winsauer PJ. Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats. Behavioural Pharmacology. 14: 509-16. PMID 14557718 DOI: 10.1097/00008877-200311000-00003  0.674
2003 Lee H, Naughton NN, Woods JH, Ko MC. Characterization of scratching responses in rats following centrally administered morphine or bombesin. Behavioural Pharmacology. 14: 501-8. PMID 14557717 DOI: 10.1097/01.fbp.0000095082.80017.0f  0.448
2003 Ko MC, Willmont KJ, Lee H, Flory GS, Woods JH. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys. Brain Research. 982: 38-44. PMID 12915238 DOI: 10.1016/S0006-8993(03)02938-X  0.825
2003 Greenwald MK, Johanson CE, Moody DE, Woods JH, Kilbourn MR, Koeppe RA, Schuster CR, Zubieta JK. Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 2000-9. PMID 12902992 DOI: 10.1038/Sj.Npp.1300251  0.72
2003 Greiner E, Spetea M, Krassnig R, Schüllner F, Aceto M, Harris LS, Traynor JR, Woods JH, Coop A, Schmidhammer H. Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships. Journal of Medicinal Chemistry. 46: 1758-63. PMID 12699394 DOI: 10.1021/jm021118o  0.397
2003 Williams KL, Ko MC, Rice KC, Woods JH. Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys. Psychoneuroendocrinology. 28: 513-28. PMID 12689609 DOI: 10.1016/S0306-4530(02)00037-9  0.467
2003 Ko MC, Lee H, Harrison C, Clark MJ, Song HF, Naughton NN, Woods JH, Traynor JR. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys. The Journal of Pharmacology and Experimental Therapeutics. 306: 179-86. PMID 12676881 DOI: 10.1124/jpet.103.050625  0.405
2003 Ko MC, Lee H, Song MS, Sobczyk-Kojiro K, Mosberg HI, Kishioka S, Woods JH, Naughton NN. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys. The Journal of Pharmacology and Experimental Therapeutics. 305: 173-9. PMID 12649366 DOI: 10.1124/Jpet.102.044909  0.469
2003 Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, Woods JH. Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology. 166: 202-11. PMID 12563544 DOI: 10.1007/S00213-002-1261-5  0.643
2003 Flory GS, Woods JH. The ascending limb of the cocaine dose-response curve for reinforcing effect in rhesus monkeys. Psychopharmacology. 166: 91-4. PMID 12529810 DOI: 10.1007/S00213-002-1336-3  0.825
2003 May EL, Coop A, Woods JH, Aceto MD, Bowman ER, Harris LS, Traynor JR. N-(trifluoromethyl)benzyl substituted N-normetazocines and N-norketobemidones. Bioorganic & Medicinal Chemistry. 11: 31-3. PMID 12467704 DOI: 10.1016/S0968-0896(02)00435-2  0.362
2002 Broadbear JH, Winger G, Rice KC, Woods JH. Antalarmin, a putative CRH-RI antagonist, has transient reinforcing effects in rhesus monkeys. Psychopharmacology. 164: 268-76. PMID 12424550 DOI: 10.1007/S00213-002-1187-Y  0.412
2002 Broom DC, Jutkiewicz EM, Rice KC, Traynor JR, Woods JH. Behavioral effects of delta-opioid receptor agonists: potential antidepressants? Japanese Journal of Pharmacology. 90: 1-6. PMID 12396021 DOI: 10.1254/Jjp.90.1  0.825
2002 Broom DC, Nitsche JF, Pintar JE, Rice KC, Woods JH, Traynor JR. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice. The Journal of Pharmacology and Experimental Therapeutics. 303: 723-9. PMID 12388657 DOI: 10.1124/Jpet.102.036525  0.802
2002 Woods JH, France CP. Determinants of the behavioral effects of opioids and their antagonists: contributions of the Laboratory of Psychobiology. Psychopharmacology. 163: 406-11. PMID 12373441 DOI: 10.1007/s00213-002-1212-1  0.561
2002 Woods JH, Winger GD. Observing responses maintained by stimuli associated with cocaine or remifentanil reinforcement in rhesus monkeys. Psychopharmacology. 163: 345-51. PMID 12373435 DOI: 10.1007/s00213-002-1201-4  0.354
2002 Broom DC, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC, Woods JH. Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats. Psychopharmacology. 164: 42-8. PMID 12373418 DOI: 10.1007/S00213-002-1179-Y  0.824
2002 Fantegrossi WE, Ullrich T, Rice KC, Woods JH, Winger G. 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology. 161: 356-64. PMID 12073162 DOI: 10.1007/S00213-002-1021-6  0.72
2002 Koetzner L, Woods JH. Characterization of equine butyrylcholinesterase disposition in the mouse. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 724-30. PMID 12019201 DOI: 10.1124/Dmd.30.6.724  0.749
2002 Koetzner L, Woods JH. Characterization of butyrylcholinesterase antagonism of cocaine-induced hyperactivity. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 716-23. PMID 12019200 DOI: 10.1124/Dmd.30.6.716  0.761
2002 Broom DC, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC, Woods JH. Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 744-55. PMID 12007745 DOI: 10.1016/S0893-133X(01)00413-4  0.824
2002 Ko MC, Terner J, Hursh S, Woods JH, Winger G. Relative reinforcing effects of three opioids with different durations of action. The Journal of Pharmacology and Experimental Therapeutics. 301: 698-704. PMID 11961075 DOI: 10.1124/jpet.301.2.698  0.317
2002 Ko MC, Naughton NN, Traynor JR, Song MS, Woods JH, Rice KC, McKnight AT. Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptors. British Journal of Pharmacology. 135: 943-50. PMID 11861322 DOI: 10.1038/Sj.Bjp.0704535  0.453
2002 Koetzner L, Sumpter TL, Woods JH. Tetrabenazine fails to antagonize a behavioral effect of cocaine in rhesus monkeys. Pharmacology, Biochemistry, and Behavior. 71: 1-5. PMID 11812502 DOI: 10.1016/S0091-3057(01)00532-9  0.772
2002 Alt A, Clark MJ, Woods JH, Traynor JR. Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells. British Journal of Pharmacology. 135: 217-25. PMID 11786497 DOI: 10.1038/Sj.Bjp.0704430  0.719
2001 Anderson KG, Winger G, Woods J, Woolverton WL. Reinforcing and discriminative-stimulus effects of ephedrine isomers in rhesus monkeys. Drug and Alcohol Dependence. 65: 45-53. PMID 11714589 DOI: 10.1016/S0376-8716(01)00143-0  0.489
2001 Houshyar H, Galigniana MD, Pratt WB, Woods JH. Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses. Journal of Neuroendocrinology. 13: 875-86. PMID 11679056 DOI: 10.1046/j.1365-2826.2001.00714.x  0.754
2001 Houshyar H, Cooper ZD, Woods JH. Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal responses to acute restraint stress: a chronic stress paradigm. Journal of Neuroendocrinology. 13: 862-74. PMID 11679055 DOI: 10.1046/J.1365-2826.2001.00713.X  0.807
2001 Butelman ER, Ko MC, Traynor JR, Vivian JA, Kreek MJ, Woods JH. GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 298: 1049-59. PMID 11504802  0.34
2001 Briscoe RJ, Jeanville PM, Cabrera C, Baird TJ, Woods JH, Landry DW. A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis. International Immunopharmacology. 1: 1189-98. PMID 11407313 DOI: 10.1016/S1567-5769(01)00054-6  0.418
2001 Gerak LR, Woolverton WL, Nader MA, Patrick GA, Harris LS, Winger G, Woods JH, France CP. Behavioral effects of flunitrazepam: reinforcing and discriminative stimulus effects in rhesus monkeys and prevention of withdrawal signs in pentobarbital-dependent rats. Drug and Alcohol Dependence. 63: 39-49. PMID 11297830 DOI: 10.1016/S0376-8716(00)00189-7  0.736
2001 Winger G, Woods JH. The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys. Drug and Alcohol Dependence. 62: 181-9. PMID 11295322 DOI: 10.1016/S0376-8716(00)00166-6  0.529
2001 Koetzner L, Deng S, Sumpter TL, Weisslitz M, Abner RT, Landry DW, Woods JH. Titer-dependent antagonism of cocaine following active immunization in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 296: 789-96. PMID 11181908  0.737
2000 May EL, Jacobson AE, Mattson MV, Traynor JR, Woods JH, Harris LS, Bowman ER, Aceto MD. Synthesis and in vitro and in vivo activity of (-)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-alkenyl-, -N-alkynyl-, and -N-cyanoalkyl-5, 9-dimethyl-2'-hydroxy-6,7-benzomorphan homologues. Journal of Medicinal Chemistry. 43: 5030-6. PMID 11150174 DOI: 10.1021/jm000317  0.338
2000 Baird TJ, Deng SX, Landry DW, Winger G, Woods JH. Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. The Journal of Pharmacology and Experimental Therapeutics. 295: 1127-34. PMID 11082449  0.363
2000 Coop A, Jacobson AE, Aceto MD, Harris LS, Traynor JR, Woods JH, Rice KC. N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole. Bioorganic & Medicinal Chemistry Letters. 10: 2449-51. PMID 11078198 DOI: 10.1016/S0960-894X(00)00479-0  0.39
2000 Briscoe RJ, Cabrera CL, Baird TJ, Rice KC, Woods JH. Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats. Brain Research. 881: 204-7. PMID 11036160 DOI: 10.1016/S0006-8993(00)02742-6  0.378
2000 McFadyen IJ, Houshyar H, Liu-Chen LY, Woods JH, Traynor JR. The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophore. Molecular Pharmacology. 58: 669-76. PMID 10999935 DOI: 10.1124/Mol.58.4.669  0.786
2000 Derrick I, Neilan CL, Andes J, Husbands SM, Woods JH, Traynor JR, Lewis JW. 3-Deoxyclocinnamox: the first high-affinity, nonpeptide mu-opioid antagonist lacking a phenolic hydroxyl group. Journal of Medicinal Chemistry. 43: 3348-50. PMID 10966754 DOI: 10.1021/Jm0009641  0.401
2000 Broom DC, Guo L, Coop A, Husbands SM, Lewis JW, Woods JH, Traynor JR. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice. The Journal of Pharmacology and Experimental Therapeutics. 294: 1195-200. PMID 10945877  0.802
2000 Zubieta J, Greenwald MK, Lombardi U, Woods JH, Kilbourn MR, Jewett DM, Koeppe RA, Schuster CR, Johanson CE. Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 326-34. PMID 10942856 DOI: 10.1016/S0893-133X(00)00110-X  0.733
2000 Ko MC, Willmont KJ, Burritt A, Hruby VJ, Woods JH. Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys. European Journal of Pharmacology. 402: 69-76. PMID 10940359 DOI: 10.1016/S0014-2999(00)00503-3  0.46
2000 Briscoe RJ, Winger G, Lewis JW, Woods JH. Methoclocinnamox: time course of changes in alfentanil-reinforced responding in rhesus monkeys. Psychopharmacology. 148: 393-9. PMID 10928312 DOI: 10.1007/S002130050068  0.512
2000 Kishioka S, Paronis CA, Woods JH. Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys. European Journal of Pharmacology. 398: 121-30. PMID 10856456 DOI: 10.1016/S0014-2999(00)00279-X  0.388
2000 Kishioka S, Ko MC, Woods JH. Diltiazem enhances the analgesic but not the respiratory depressant effects of morphine in rhesus monkeys. European Journal of Pharmacology. 397: 85-92. PMID 10844102 DOI: 10.1016/S0014-2999(00)00248-X  0.471
2000 Remmers AE, Clark MJ, Alt A, Medzihradsky F, Woods JH, Traynor JR. Activation of G protein by opioid receptors: role of receptor number and G-protein concentration. European Journal of Pharmacology. 396: 67-75. PMID 10822058 DOI: 10.1016/S0014-2999(00)00212-0  0.721
2000 Houshyar H, Mc Fadyen IJ, Woods JH, Traynor JR. Antinociceptive and other behavioral effects of the steroid SC17599 are mediated by the mu-opioid receptor. European Journal of Pharmacology. 395: 121-8. PMID 10794817 DOI: 10.1016/S0014-2999(00)00176-X  0.801
2000 Kishioka S, Paronis CA, Lewis JW, Woods JH. Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys. European Journal of Pharmacology. 391: 289-97. PMID 10729371 DOI: 10.1016/S0014-2999(00)00039-X  0.495
2000 Ko MC, Tuchman JE, Johnson MD, Wiesenauer K, Woods JH. Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats. Psychopharmacology. 148: 180-5. PMID 10663433 DOI: 10.1007/S002130050040  0.47
2000 Derrick I, Husbands SM, Broadbear J, Traynor JR, Woods JH, Lewis JW. Cinnamoyl derivatives of 7a-amino- and 7a-(aminomethyl)- N-(cyclopropylmethyl)-6,14-endo-ethanotetrahydronororipavines are high-potency opioid antagonists Helvetica Chimica Acta. 83: 3122-3130. DOI: 10.1002/1522-2675(20001220)83:12<3122::Aid-Hlca3122>3.0.Co;2-2  0.349
1999 Patrick CA, Holden Ko MC, Woods JH. Comparison of Antinociceptive Effects Induced by Kappa Opioid Agonists in Male and Female Mice. Analgesia (Elmsford, N.Y.). 4: 397-404. PMID 21687823  0.337
1999 Vivian JA, Sumpter TL, Woods JH. Further characterization of the quinine taste discrimination stimulus in rhesus monkeys: effects of inter-trial interval, number and distribution of test stimuli. Behavioural Pharmacology. 10: 313-8. PMID 10780245 DOI: 10.1097/00008877-199905000-00007  0.301
1999 Vivian JA, Liang YJ, Higley JD, Linnoila M, Woods JH. Oral self-administration of ethanol, phencyclidine, methadone, pentobarbital and quinine in rhesus monkeys. Psychopharmacology. 147: 113-24. PMID 10591878 DOI: 10.1007/S002130051151  0.369
1999 Broadbear JH, Winger G, Woods JH. Glucocorticoid-reinforced responding in the rhesus monkey. Psychopharmacology. 147: 46-55. PMID 10591868 DOI: 10.1007/s002130051141  0.408
1999 Ko MC, Johnson MD, Butelman ER, Willmont KJ, Mosberg HI, Woods JH. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 291: 1113-20. PMID 10565831  0.356
1999 Neilan CL, Akil H, Woods JH, Traynor JR. Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists. British Journal of Pharmacology. 128: 556-62. PMID 10516632 DOI: 10.1038/sj.bjp.0702816  0.421
1999 Lee KO, Akil H, Woods JH, Traynor JR. Differential binding properties of oripavines at cloned mu- and delta-opioid receptors. European Journal of Pharmacology. 378: 323-30. PMID 10493109 DOI: 10.1016/S0014-2999(99)00460-4  0.43
1999 Rowlett JK, Winger G, Carter RB, Wood PL, Woods JH, Woolverton WL. Reinforcing and discriminative stimulus effects of the neuroactive steroids pregnanolone and Co 8-7071 in rhesus monkeys. Psychopharmacology. 145: 205-12. PMID 10463322 DOI: 10.1007/S002130051050  0.422
1999 Broadbear JH, Winger G, Woods JH. Cocaine-reinforced responding in rhesus monkeys: pharmacological attenuation of the hypothalamic-pituitary-adrenal axis response. The Journal of Pharmacology and Experimental Therapeutics. 290: 1347-55. PMID 10454513  0.346
1999 Williams KL, Pakarinen ED, Woods JH. Quadazocine decreases responding reinforced by ethanol, sucrose, and phencyclidine fluid deliveries in rhesus monkeys: comparison to naltrexone's effects. Psychopharmacology. 144: 316-22. PMID 10435403 DOI: 10.1007/s002130051013  0.455
1999 Broadbear JH, Winger G, Cicero TJ, Woods JH. Effects of response contingent and noncontingent cocaine injection on hypothalamic-pituitary-adrenal activity in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 290: 393-402. PMID 10381805  0.34
1999 Vivian JA, DeYoung MB, Sumpter TL, Traynor JR, Lewis JW, Woods JH. kappa-Opioid receptor effects of butorphanol in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 290: 259-65. PMID 10381785  0.378
1999 Ko MC, Woods JH. Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action. Psychopharmacology. 143: 322-6. PMID 10353438 DOI: 10.1007/s002130050955  0.384
1999 Broadbear JH, Winger G, Cicero TJ, Woods JH. Effects of self-administered cocaine on plasma adrenocorticotropic hormone and cortisol in male rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 289: 1641-7. PMID 10336563  0.329
1999 Butelman ER, Vivian JA, Yu J, Kreek MJ, Woods JH. Systemic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys. Psychopharmacology. 143: 190-6. PMID 10326782 DOI: 10.1007/S002130050935  0.45
1999 Williams KL, Woods JH. Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys. Alcoholism, Clinical and Experimental Research. 23: 708-15. PMID 10235307 DOI: 10.1097/00000374-199904001-00018  0.39
1999 Woolverton WL, Rowlett JK, Winger G, Woods JH, Gerak LR, France CP. Evaluation of the reinforcing and discriminative stimulus effects of gamma-hydroxybutyrate in rhesus monkeys. Drug and Alcohol Dependence. 54: 137-43. PMID 10217553 DOI: 10.1016/S0376-8716(98)00153-7  0.738
1999 Ko MC, Butelman ER, Woods JH. Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 289: 378-85. PMID 10087027  0.373
1999 Naughton NN, Ko MC, Johnson MD, Willmont KJ, Woods JH. Characterization of Morphine Induced Pruritus and Antinociception in an Experimental Monkey Model Anesthesiology. 90. DOI: 10.1097/00000542-199904001-00020  0.377
1998 Williams KL, Woods JH. Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor. Alcoholism, Clinical and Experimental Research. 22: 1634-9. PMID 9835275 DOI: 10.1111/J.1530-0277.1998.Tb03960.X  0.416
1998 Williams KL, Winger G, Pakarinen ED, Woods JH. Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys. Psychopharmacology. 139: 53-61. PMID 9768542 DOI: 10.1007/S002130050689  0.318
1998 Husbands SM, Sadd J, Broadbear JH, Woods JH, Martin J, Traynor JR, Aceto MD, Bowman ER, Harris LS, Lewis JW. 3-Alkyl ethers of clocinnamox: delayed long-term mu-antagonists with variable mu efficacy. Journal of Medicinal Chemistry. 41: 3493-8. PMID 9719602 DOI: 10.1021/Jm9810248  0.462
1998 Lieberman PB, Woods JH, Young EA. The role of endogenous opioids in the luteinizing hormone surge in rats: studies with clocinnamox, a long-lasting opioid receptor antagonist. European Journal of Pharmacology. 352: 73-9. PMID 9718270 DOI: 10.1016/S0014-2999(98)00341-0  0.433
1998 Mets B, Winger G, Cabrera C, Seo S, Jamdar S, Yang G, Zhao K, Briscoe RJ, Almonte R, Woods JH, Landry DW. A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats. Proceedings of the National Academy of Sciences of the United States of America. 95: 10176-81. PMID 9707620 DOI: 10.1073/Pnas.95.17.10176  0.419
1998 Vivian JA, Kishioka S, Butelman ER, Broadbear J, Lee KO, Woods JH. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A. The Journal of Pharmacology and Experimental Therapeutics. 286: 697-703. PMID 9694923  0.317
1998 France CP, Gerak LR, Rowlett JK, Woolverton WL, Winger G, Woods JH. Progress report from the testing program for stimulant and depressant drugs (1996). Nida Research Monograph. 178: 429-39. PMID 9686406  0.645
1998 Alt A, Mansour A, Akil H, Medzihradsky F, Traynor JR, Woods JH. Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor. The Journal of Pharmacology and Experimental Therapeutics. 286: 282-8. PMID 9655870  0.307
1998 Ko MC, Butelman ER, Woods JH. The role of peripheral mu opioid receptors in the modulation of capsaicin-induced thermal nociception in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 286: 150-6. PMID 9655854  0.375
1998 Butelman ER, Ko MC, Sobczyk-Kojiro K, Mosberg HI, Van Bemmel B, Zernig G, Woods JH. kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception. The Journal of Pharmacology and Experimental Therapeutics. 285: 595-601. PMID 9580603  0.332
1998 Ko MC, Butelman ER, Traynor JR, Woods JH. Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 285: 518-26. PMID 9580592  0.351
1998 Elmer GI, Pieper JO, Negus SS, Woods JH. Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain. 75: 129-40. PMID 9539682 DOI: 10.1016/S0304-3959(97)00215-7  0.34
1997 Paronis CA, Woods JH. Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats. European Journal of Pharmacology. 337: 27-34. PMID 9389377 DOI: 10.1016/S0014-2999(97)01296-X  0.445
1997 Paronis CA, Woods JH. Ventilation in morphine-maintained rhesus monkeys. I: Effects of naltrexone and abstinence-associated withdrawal. The Journal of Pharmacology and Experimental Therapeutics. 282: 348-54. PMID 9223573  0.316
1997 Woods JH, Winger G. Abuse liability of flunitrazepam. Journal of Clinical Psychopharmacology. 17: 1S-57S. PMID 9169981 DOI: 10.1097/00004714-199706001-00001  0.41
1997 Zernig G, Lewis JW, Woods JH. Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception. Psychopharmacology. 129: 233-42. PMID 9084061 DOI: 10.1007/S002130050185  0.49
1996 Winger G, Woods JH. Effects of buprenorphine on behaviour maintained by heroin and alfentanil in rhesus monkeys. Behavioural Pharmacology. 7: 155-159. PMID 11224407  0.389
1996 Derrick I, Lewis JW, Moynihan HA, Broadbear J, Woods JH. Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of beta-naltrexamine. The Journal of Pharmacy and Pharmacology. 48: 192-6. PMID 8935170 DOI: 10.1111/j.2042-7158.1996.tb07121.x  0.381
1996 Butelman ER, Lewis JW, Woods JH. Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 279: 934-8. PMID 8930202  0.367
1996 Jewett DC, Mosberg HI, Woods JH. Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin) in pigeons. Psychopharmacology. 127: 225-30. PMID 8912400 DOI: 10.1007/Bf02246130  0.471
1996 Acteo MD, Bowman E, Butelman E, Englis JA, Harrish L, Jacobson AE, Mattson MV, Medzihradsky F, Patrick G, Rowlett JK, Smith CB, Winger G, Woods JH, Woolverton WL. Zipeprol: preclinical assessment of abuse potential. Drug and Alcohol Dependence. 42: 93-104. PMID 8889408 DOI: 10.1016/0376-8716(96)01267-7  0.496
1996 Butelman ER, Negus SS, Lewis JW, Woods JH. Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys. Psychopharmacology. 123: 320-4. PMID 8867870 DOI: 10.1007/Bf02246641  0.492
1996 Zernig G, Issaevitch T, Woods JH. Calculation of agonist efficacy, apparent affinity, and receptor population changes after administration of insurmountable antagonists: comparison of different analytical approaches. Journal of Pharmacological and Toxicological Methods. 35: 223-37. PMID 8823669 DOI: 10.1016/1056-8719(96)00053-6  0.354
1996 Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. The Journal of Pharmacology and Experimental Therapeutics. 278: 1121-7. PMID 8819494  0.325
1996 Jewett DC, Butelman ER, Woods JH. Nitric oxide synthase inhibitors produce phencyclidine-like behavioral effects in pigeons. Brain Research. 715: 25-31. PMID 8739619 DOI: 10.1016/0006-8993(95)01328-8  0.337
1996 Winger G, Woods JH, Hursh SR. Behavior maintained by alfentanil or nalbuphine in rhesus monkeys: Fixed-ratio and time-out changes to establish demand curves and relative reinforcing effectiveness Experimental and Clinical Psychopharmacology. 4: 131-140. DOI: 10.1037/1064-1297.4.2.131  0.314
1996 Derrick I, Moynihan HA, Broadbear J, Woods JH, Lewis JW. 6N-Cinnamoyl-β-naltrexamine and its p-nitro derivative. High efficacy κ-opioid agonists with weak antagonist actions Bioorganic & Medicinal Chemistry Letters. 6: 167-172. DOI: 10.1016/0960-894X(95)00583-F  0.384
1996 Broadbear JH, Lewis JW, Woods JH. Alternative pharmacotherapies in the treatment of opioid addiction European Neuropsychopharmacology. 6: 120. DOI: 10.1016/0924-977X(96)87855-2  0.401
1995 Jewett DC, Woods JH. Nor-binaltorphimine: an ultra-long acting kappa-opioid antagonist in pigeons. Behavioural Pharmacology. 6: 815-820. PMID 11224385  0.384
1995 Woods JH, Lewis JW, Winger G, Butelman E, Broadbear J, Zernig G. Methoclocinnamox: a mu partial agonist with pharmacotherapeutic potential for heroin abuse. Nida Research Monograph. 147: 195-219. PMID 8742788  0.334
1995 Butelman ER, Winger G, Zernig G, Woods JH. Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 272: 845-53. PMID 7853203  0.34
1995 Pakarinen ED, Woods JH, Moerschbaecher JM. Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist. The Journal of Pharmacology and Experimental Therapeutics. 272: 552-9. PMID 7853168  0.374
1995 Walker EA, Zernig G, Woods JH. Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure. The Journal of Pharmacology and Experimental Therapeutics. 273: 1345-52. PMID 7791107  0.685
1995 Negus SS, Butelman ER, Gatch MB, Woods JH. Effects of morphine and ketorolac on thermal allodynia induced by prostaglandin E2 and bradykinin in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 274: 805-14. PMID 7636744  0.354
1995 Woods JH, Winger G. Current benzodiazepine issues. Psychopharmacology. 118: 107-15; discussion 1. PMID 7617794 DOI: 10.1007/Bf02245824  0.328
1995 France CP, Gerak LR, Flynn D, Winger GD, Medzihradsky F, Bagley JR, Brockunier LL, Woods JH. Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 274: 17-28. PMID 7616395  0.753
1995 Baron SP, Woods JH. Competitive and uncompetitive N-methyl-D-aspartate antagonist discriminations in pigeons: CGS 19755 and phencyclidine. Psychopharmacology. 118: 42-51. PMID 7597121 DOI: 10.1007/Bf02245248  0.365
1995 Butelman ER, France CP, Woods JH. Agonist and antagonist effects of dynorphin A-(1-13) in a thermal antinociception assay in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 275: 374-80. PMID 7562573  0.594
1995 Butelman ER, Negus SS, Gatch MB, Chang KJ, Woods JH. BW373U86, a delta-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys. European Journal of Pharmacology. 277: 285-7. PMID 7493622 DOI: 10.1016/0014-2999(95)00134-7  0.484
1995 Zernig G, Issaevitch T, Broadbear JH, Burke TF, Lewis JW, Brine GA, Woods JH. Receptor reserve and affinity of mu opioid agonists in mouse antinociception: correlation with receptor binding. Life Sciences. 57: 2113-25. PMID 7475964 DOI: 10.1016/0024-3205(95)02204-V  0.456
1995 Woods JH, Winger G, Pakarinen E, Aspen J. Reinforcing Effects Of Nmda Antagonists In Rhesus Monkeys Behavioural Pharmacology. 6. DOI: 10.1097/00008877-199508000-00090  0.328
1995 Zernig G, Broadbear J, Lewis JW, Brine GA, Woods JH. Opioid Agonist Effects on Mouse Writhing After Irreversible Mu Receptor Blockade With Clocinnamox Experimental and Clinical Psychopharmacology. 3: 323-329. DOI: 10.1037/1064-1297.3.4.323  0.444
1994 Takasuna M, Negus SS, DeCosta BR, Woods JH. Opioid pharmacology of the antinociceptive effects of loperamide in mice. Behavioural Pharmacology. 5: 189-195. PMID 11224267 DOI: 10.1097/00008877-199404000-00010  0.492
1994 Woods JH, France CP, Medzihradsky F, Smith CB, Winger GD. Evaluation of new compounds for opioid activity annual report (1993). Nida Research Monograph. 140: 196-247. PMID 8722466  0.518
1994 France CP, Medzihradsky F, Woods JH. Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities. The Journal of Pharmacology and Experimental Therapeutics. 268: 47-58. PMID 8301589  0.57
1994 Zernig G, Butelman ER, Lewis JW, Walker EA, Woods JH. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox. The Journal of Pharmacology and Experimental Therapeutics. 269: 57-65. PMID 8169852  0.694
1994 Gerak LR, Butelman ER, Woods JH, France CP. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 271: 993-9. PMID 7965822  0.757
1994 Burke TF, Woods JH, Lewis JW, Medzihradsky F. Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice. The Journal of Pharmacology and Experimental Therapeutics. 271: 715-21. PMID 7965787  0.354
1994 Negus SS, Butelman ER, Chang KJ, DeCosta B, Winger G, Woods JH. Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 270: 1025-34. PMID 7932149  0.386
1994 Broadbear JH, Negus SS, Butelman ER, de Costa BR, Woods JH. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay. Psychopharmacology. 115: 311-9. PMID 7871070 DOI: 10.1007/Bf02245071  0.482
1994 Zernig G, Burke T, Lewis J, Woods J. Clocinnamox blocks only mu receptors irreversibly: Binding evidence Regulatory Peptides. 54: 343-344. DOI: 10.1016/0167-0115(94)90529-0  0.331
1994 Zernig G, Butelman ER, Lewis J, Woods JH. In vivo determination of μ opioid receptor reserve and turnover in rhesus monkeys after irreversible blockade with clocinnamox Regulatory Peptides. 53: S59-S60. DOI: 10.1016/0167-0115(94)90240-2  0.453
1994 Woods JH. New pharmacotherapies for heroin addiction Pharmacology, Biochemistry and Behavior. 48: 825. DOI: 10.1016/0091-3057(94)90361-1  0.301
1993 France CP, Woods JH. U-50, 488, saline and naltrexone discrimination in U-50, 488-treated pigeons. Behavioural Pharmacology. 4: 509-516. PMID 11224218  0.593
1993 Baron SP, Woods JH. Effects of phencyclidine and dizocilpine on NMDA-, kainate-, and water deprivation-induced drinking in pigeons. Behavioural Pharmacology. 4: 257-261. PMID 11224193 DOI: 10.1097/00008877-199306000-00008  0.315
1993 Baron SP, Butelman ER, Woods JH. Discriminative stimulus effects of NMDA in pigeons and monkeys. Behavioural Pharmacology. 4: 115-123. PMID 11224178 DOI: 10.1097/00008877-199304000-00004  0.334
1993 Butelman ER, Baron SP, Woods JH. Ethanol effects in pigeons trained to discriminate MK-801, PCP or CGS-19755. Behavioural Pharmacology. 4: 57-60. PMID 11224171 DOI: 10.1097/00008877-199302000-00006  0.329
1993 Woods JH, France CP, Medzihradsky F, Smith CB, Winger GD. Evaluation of new compounds for opioid activity, 1992. Nida Research Monograph. 132: 517-78. PMID 8393529  0.521
1993 Negus SS, Butelman ER, Al Y, Woods JH. Prostaglandin E2-induced thermal hyperalgesia and its reversal by morphine in the warm-water tail-withdrawal procedure in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 266: 1355-63. PMID 8371142  0.37
1993 Skjoldager P, Winger G, Woods JH. Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys. Drug and Alcohol Dependence. 33: 31-9. PMID 8370338 DOI: 10.1016/0376-8716(93)90031-K  0.441
1993 Butelman ER, Negus SS, Ai Y, de Costa BR, Woods JH. Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 267: 1269-76. PMID 8263790  0.394
1993 Negus SS, Burke TF, Medzihradsky F, Woods JH. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine. The Journal of Pharmacology and Experimental Therapeutics. 267: 896-903. PMID 8246165  0.375
1993 Comer SD, Hoenicke EM, Sable AI, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH. Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. The Journal of Pharmacology and Experimental Therapeutics. 267: 888-95. PMID 8246164  0.341
1993 Comer SD, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH. Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors. The Journal of Pharmacology and Experimental Therapeutics. 267: 866-74. PMID 8246161  0.381
1993 Butelman ER, Woods JH. Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 264: 762-9. PMID 8094751  0.358
1993 Butelman ER, France CP, Woods JH. Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 264: 145-51. PMID 8093721  0.561
1993 Walker EA, Butelman ER, DeCosta BR, Woods JH. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. The Journal of Pharmacology and Experimental Therapeutics. 267: 280-6. PMID 7901396  0.694
1992 France CP, Woods JH. Naloxone benzylhydrazone is a µ-selective opioid antagonist without kappa agonist effects in rhesus monkeys. Behavioural Pharmacology. 3: 133-141. PMID 11224111  0.616
1992 Winger G, Skjoldager P, Woods JH. Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 261: 311-7. PMID 1560376  0.423
1992 Woods JH, Winger G, France CP. Use of in vivo apparent pA2 analysis in assessment of opioid abuse liability. Trends in Pharmacological Sciences. 13: 282-6. PMID 1509522 DOI: 10.1016/0165-6147(92)90086-L  0.621
1992 Woods JH, Medzihradsky F, Smith CB, Winger GD, France CP. Evaluation of new compounds for opioid activity (1991). Nida Research Monograph. 119: 559-603. PMID 1435986  0.521
1992 Lu Y, France CP, Woods JH. Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists. The Journal of Pharmacology and Experimental Therapeutics. 263: 499-504. PMID 1432686  0.504
1992 Woods JH, France CP, Winger GD. Behavioral pharmacology of buprenorphine: issues relevant to its potential in treating drug abuse. Nida Research Monograph. 121: 12-27. PMID 1406907  0.489
1992 France CP, Winger G, Seggel MR, Rice KC, Woods JH. Pharmacological profile of a potent, efficacious fentanyl derivative in rhesus monkeys. Psychopharmacology. 109: 291-8. PMID 1365629 DOI: 10.1007/Bf02245876  0.616
1992 Bertalmio AJ, Woods JH. Discriminative stimulus effects of cyclorphan: selective antagonism with naltrexone. Psychopharmacology. 106: 189-94. PMID 1347952 DOI: 10.1007/Bf02801971  0.448
1992 Winger G, France CP, Woods JH, Smith CB, Medzihradsky F, Iorio MA. Opioid and non-opioid effects of novel butyrophenone analogues. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 7: 177-87. PMID 1326980  0.607
1992 Comer SD, Burke TF, Lewis JW, Woods JH. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist. The Journal of Pharmacology and Experimental Therapeutics. 262: 1051-6. PMID 1326622  0.366
1992 Bertalmio AJ, Medzihradsky F, Winger G, Woods JH. Differential influence of N-dealkylation on the stimulus properties of some opioid agonists. The Journal of Pharmacology and Experimental Therapeutics. 261: 278-84. PMID 1313871  0.315
1991 Butelman ER, France CP, Woods JH. The discriminative stimulus effects of MK-801 in pigeons. Behavioural Pharmacology. 2: 79-86. PMID 11224051  0.542
1991 France CP, Moerschbaecher JM, Woods JH. MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination. The Journal of Pharmacology and Experimental Therapeutics. 257: 727-34. PMID 2033515  0.545
1991 Nader MA, Winger G, Woods JH, Woolverton WL. Discriminative and reinforcing effects of brotizolam in rhesus monkeys. Psychopharmacology. 103: 166-71. PMID 2027918 DOI: 10.1007/Bf02244198  0.405
1991 Skjoldager P, Winger G, Woods JH. Analysis of fixed-ratio behavior maintained by drug reinforcers. Journal of the Experimental Analysis of Behavior. 56: 331-43. PMID 1955820 DOI: 10.1901/jeab.1991.56-331  0.396
1991 Walker EA, Yamamoto T, Hollingsworth PJ, Smith CB, Woods JH. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon. The Journal of Pharmacology and Experimental Therapeutics. 259: 772-82. PMID 1941625  0.572
1991 Yamamoto T, Walker EA, Woods JH. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan. The Journal of Pharmacology and Experimental Therapeutics. 258: 999-1007. PMID 1890629  0.597
1991 France CP, Winger G, Medzihradsky F, Seggel MR, Rice KC, Woods JH. Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects. The Journal of Pharmacology and Experimental Therapeutics. 258: 502-10. PMID 1650830  0.623
1991 Comer SD, France CP, Woods JH. Training dose: influences in opioid drug discrimination. Nida Research Monograph. 145-61. PMID 1369665 DOI: 10.1037/E496182006-010  0.539
1990 France CP, Woods JH. Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons. The Journal of Pharmacology and Experimental Therapeutics. 254: 626-32. PMID 2384889  0.604
1990 Thurkauf A, de Costa B, Mattson MV, France CP, Price MT, Olney JW, Woods JH, Jacobson AE, Rice KC. Synthesis, phencyclidine-like pharmacology, and antiischemic potential of meta-substituted 1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridines. Journal of Medicinal Chemistry. 33: 2211-5. PMID 2374147 DOI: 10.1021/Jm00170A027  0.532
1990 France CP, Lu Y, Woods JH. Interactions between N-methyl-D-aspartate and CGS 19755 administered intramuscularly and intracerebroventricularly in pigeons. The Journal of Pharmacology and Experimental Therapeutics. 255: 1271-7. PMID 2262905  0.484
1990 France CP, Winger GD, Woods JH. Analgesic, anesthetic, and respiratory effects of the competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 in rhesus monkeys. Brain Research. 526: 355-8. PMID 2257491 DOI: 10.1016/0006-8993(90)91247-E  0.57
1990 France CP, de Costa BR, Jacobson AE, Rice KC, Woods JH. Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone. The Journal of Pharmacology and Experimental Therapeutics. 252: 600-4. PMID 2156055  0.618
1990 France CP, Woods JH. Respiratory effects of receptor-selective opioids in rhesus monkeys. Progress in Clinical and Biological Research. 328: 295-8. PMID 2154784  0.572
1990 Woods JH, Medzihradsky F, Smith CB, Winger GD, France CP. Evaluation of new compounds for opioid activity (1990). Nida Research Monograph. 105: 682-724. PMID 1876152  0.521
1990 Walker EA, Woods JH. Apparent affinity estimates for nalbuphine, an opioid partial agonist, in a rhesus monkey tail-withdrawal procedure European Journal of Pharmacology. 183: 2304. DOI: 10.1016/0014-2999(90)93857-M  0.683
1989 Winger GD, Palmer RK, Woods JH. Drug-reinforced responding: rapid determination of dose-response functions Drug and Alcohol Dependence. 24: 135-142. PMID 2676442 DOI: 10.1016/0376-8716(89)90076-8  0.446
1989 France CP, Woods JH, Ornstein P. The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects. European Journal of Pharmacology. 159: 133-9. PMID 2651134 DOI: 10.1016/0014-2999(89)90697-3  0.573
1989 Rothman RB, France CP, Bykov V, De Costa BR, Jacobson AE, Woods JH, Rice KC. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes. European Journal of Pharmacology. 167: 345-53. PMID 2553442 DOI: 10.1016/0014-2999(89)90443-3  0.541
1989 Koek W, Woods JH. Partial generalization in pigeons trained to discriminate morphine from saline: Applications of receptor theory Drug Development Research. 16: 169-181. DOI: 10.1002/Ddr.430160211  0.443
1989 Woods JH, Winger G, Katz JL. Abuse of Benzodiazepines-Reply Jama. 261: 2956-2957. DOI: 10.1001/Jama.1989.03420200046029  0.307
1988 Koek W, Woods JH. 2-Amino-6-trifluoromethoxy benzothiazole (PK 26124), a proposed antagonist of excitatory amino acid neurotransmission, does not produce phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. Neuropharmacology. 27: 771-775. PMID 2843787 DOI: 10.1016/0028-3908(88)90089-5  0.32
1988 Woods JH, Bertalmio AJ, Young AM, Essman WD, Winger G. Receptor mechanisms of opioid drug discrimination. Psychopharmacology Series. 4: 95-106. PMID 2839823 DOI: 10.1007/978-3-642-73223-2_8  0.442
1987 France CP, Adams JU, Woods JH. Comparison of naltrexone and quaternary naltrexone after systemic and intracerebroventricular administration in pigeons. Neuropharmacology. 26: 541-8. PMID 3601009 DOI: 10.1016/0028-3908(87)90145-6  0.643
1987 France CP, Woods JH. Beta-funaltrexamine antagonizes the discriminative stimulus effects of morphine but not naltrexone in pigeons. Psychopharmacology. 91: 213-6. PMID 3107034 DOI: 10.1007/Bf00217065  0.603
1987 Koek W, Woods JH, Jacobson AE, Rice KC. Phencyclidine (PCP)-like discriminative stimulus effects of metaphit and of 2-amino-5-phosphonovalerate in pigeons: generality across different training doses of PCP Psychopharmacology. 93: 437-442. PMID 2893414 DOI: 10.1007/Bf00207232  0.361
1987 Koek W, Woods JH, Ornstein P. A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats. Psychopharmacology. 91: 297-304. PMID 2882539 DOI: 10.1007/Bf00518181  0.387
1987 Woods JH, Winger GD. Behavioral characterization of opioid mixed agonist-antagonists Drug and Alcohol Dependence. 20: 303-315. PMID 2831018 DOI: 10.1016/0376-8716(87)90004-4  0.439
1986 Dykstra LA, Woods JH. A tail withdrawal procedure for assessing analgesic activity in rhesus monkeys. Journal of Pharmacological Methods. 15: 263-9. PMID 3713205 DOI: 10.1016/0160-5402(86)90056-2  0.329
1986 Koek W, Woods JH. Response repetition in pigeons: pharmacological and behavioral specificity Psychopharmacology. 90: 475-481. PMID 3101104 DOI: 10.1007/Bf00174064  0.358
1986 Gmerek DE, Woods JH. Kappa receptor mediated opioid dependence in rhesus monkeys Life Sciences. 39: 987-992. PMID 3018406 DOI: 10.1016/0024-3205(86)90287-0  0.494
1986 Takada K, Winger GD, Cook JA, Larscheid P, Woods JH. Discriminative and aversive properties of β-carboline-3-carboxylic acid ethyl ester, a benzodiazepine receptor inverse agonist, in rhesus monkey Life Sciences. 38: 1049-1056. PMID 3005790 DOI: 10.1016/0024-3205(86)90240-7  0.318
1986 Koek W, Woods JH, Ornstein P. Phencyclidine-like behavioral effects in pigeons induced by systemic administration of the excitatory amino acid antagonist, 2-amino-5-phosphonovalerate. Life Sciences. 39: 973-8. PMID 2875374 DOI: 10.1016/0024-3205(86)90285-7  0.347
1986 Young EA, Walker JM, Lewis ME, Houghten RA, Woods JH, Akil H. [3H]dynorphin A binding and kappa selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain. European Journal of Pharmacology. 121: 355-65. PMID 2870933 DOI: 10.1016/0014-2999(86)90256-6  0.36
1986 Koek W, Kleer E, Mudar PJ, Woods JH. Phencyclidine-like catalepsy induced by the excitatory amino acid antagonist DL-2-amino-5-phosphonovalerate. Behavioural Brain Research. 19: 257-259. PMID 2870725 DOI: 10.1016/0166-4328(86)90026-4  0.341
1985 France CP, Adams JU, Woods JH. Intracerebroventricular drug administration in pigeons. Pharmacology, Biochemistry, and Behavior. 23: 731-6. PMID 4080758 DOI: 10.1016/0091-3057(85)90063-2  0.625
1985 Aceto MD, Harris LS, Woods JH, Katz JL, Smith CB, Medzihradsky F, Jacobson AE, Shiotani S. Pharmacological actions of the racemic and the enantiomeric 1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz azo nines (C-homobenzomorphans). Japanese Journal of Pharmacology. 39: 7-19. PMID 4068392 DOI: 10.1254/Jjp.39.7  0.423
1985 Woods JH, Gmerek DE. Substitution and primary dependence studies in animals. Drug and Alcohol Dependence. 14: 233-247. PMID 4039649 DOI: 10.1016/0376-8716(85)90059-6  0.501
1985 Winger GD, Woods JH. Comparison of fixed-ratio and progressive-ratio schedules of maintenance of stimulant drug-reinforced responding Drug and Alcohol Dependence. 15: 123-130. PMID 4017869 DOI: 10.1016/0376-8716(85)90036-5  0.451
1985 France CP, Woods JH. Effects of morphine, naltrexone, and dextrorphan in untreated and morphine-treated pigeons. Psychopharmacology. 85: 377-82. PMID 3923525 DOI: 10.1007/Bf00428205  0.63
1984 Koek W, Woods JH, Rice KC, Jacobson AE, Huguenin PN, Burke TR. Phencyclidine-induced catalepsy in pigeons: specificity and stereoselectivity. European Journal of Pharmacology. 106: 635-638. PMID 6542865 DOI: 10.1016/0014-2999(84)90070-0  0.308
1984 Herling S, Valentino RJ, Solomon RE, Woods JH. Narcotic discrimination in pigeons: antagonism by naltrexone. European Journal of Pharmacology. 105: 137-42. PMID 6386494 DOI: 10.1016/0014-2999(84)90657-5  0.651
1984 Medzihradsky F, Dahlstrom PJ, Woods JH, Fischel SV, Mitsos SE. Resolution in the receptor binding of putative μ and κ opiates Life Sciences. 34: 2129-2138. PMID 6145076 DOI: 10.1016/0024-3205(84)90311-4  0.365
1984 Young AM, Stephens KR, Hein DW, Woods JH. Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids. The Journal of Pharmacology and Experimental Therapeutics. 229: 118-26. PMID 6142942  0.331
1984 Smith CB, Bennett-Kelly L, Woods JH. Comparison of "selective" opiate receptor antagonists on the isolated mouse vas deferens. Neuropeptides. 5: 161-4. PMID 6099488 DOI: 10.1016/0143-4179(84)90052-0  0.377
1983 Woods JH. Some thoughts on the relations between animal and human drug-taking Progress in Neuropsychopharmacology and Biological Psychiatry. 7: 577-584. PMID 6686694 DOI: 10.1016/0278-5846(83)90028-3  0.323
1983 Gmerek DE, Katz JL, France CP, Woods JH. Systemic and intracerebroventricular effects of opioid peptides in withdrawn morphine-dependent rhesus monkeys. Life Sciences. 33: 361-4. PMID 6686632 DOI: 10.1016/0024-3205(83)90517-9  0.605
1983 Valentino RJ, Herling S, Woods JH. Discriminative stimulus effects of naltrexone in narcotic-naive and morphine-treated pigeons. The Journal of Pharmacology and Experimental Therapeutics. 224: 307-13. PMID 6681632  0.568
1983 Valentino RJ, Katz JL, Medzihradsky F, Woods JH. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists. Life Sciences. 32: 2887-96. PMID 6304445 DOI: 10.1016/0024-3205(83)90325-9  0.642
1983 Woods JH, Young AM, Medzihradsky F, Smith CB, Aceto MD, Harris LS, Jacobson AE. Zomepirac: preclinical narcotic abuse liability evaluation. Arzneimittel-Forschung. 33: 218-22. PMID 6133523  0.357
1982 Solomon RE, Herling S, Domino EF, Woods JH. Discriminative stimulus effects of N-substituted analogs of phencyclidine in rhesus monkeys. Neuropharmacology. 21: 1329-36. PMID 7155312 DOI: 10.1016/0028-3908(82)90142-3  0.416
1982 Falk JL, Schuster CR, Bigelow GE, Woods JH. Progress and needs in the experimental analysis of drug and alcohol dependence. The American Psychologist. 37: 1124-7. PMID 7149427 DOI: 10.1037/0003-066X.37.10.1124  0.481
1982 Solomon RE, Herling S, Woods JH. Discriminative stimulus effects of monohydroxylated phencyclidine metabolites in Rhesus monkeys. European Journal of Pharmacology. 82: 233-7. PMID 7128690 DOI: 10.1016/0014-2999(82)90520-9  0.381
1982 Bertalmio AJ, Herling S, Hampton RY, Winger G, Woods JH. A procedure for rapid evaluation of the discriminative stimulus effects of drugs Journal of Pharmacological Methods. 7: 289-299. PMID 7121010 DOI: 10.1016/0160-5402(82)90082-1  0.308
1982 Young AM, Woods JH. Limitations on the antagonistic actions of opioid antagonists. Federation Proceedings. 41: 2333-8. PMID 7042396  0.396
1982 Woods JH, Young AM, Herling S. Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys. Federation Proceedings. 41: 221-7. PMID 7037459  0.381
1982 Katz JL, Woods JH, Winger GD, Jacobson AE. Compounds of novel structure having kappa-agonist behavioral effects in rhesus monkeys. Life Sciences. 31: 2375-8. PMID 6298529 DOI: 10.1016/0024-3205(82)90160-6  0.376
1982 Herling S, Hein DW, Nemeth MA, Valentino RJ, Woods JH. Discriminative stimulus, antagonist, and rate-decreasing effects of cyclorphan: multiple modes of action. Life Sciences. 30: 331-41. PMID 6122153 DOI: 10.1016/0024-3205(82)90569-0  0.63
1982 Woods JH. Benzodiazepine dependence studies in animals: An overview Drug Development Research. 2: 77-81. DOI: 10.1002/Ddr.430010712  0.309
1981 Woods JH, Schuster CR, Hartel CR. Behavioral effects of thebaine in the rhesus monkey. Pharmacology, Biochemistry, and Behavior. 14: 805-9. PMID 7255516 DOI: 10.1016/0091-3057(81)90364-6  0.612
1981 Valentino RJ, Herling S, Woods JH. The relationship between the acute behavioral effects of narcotic antagonists and the narcotic-dependent state [proceedings]. Psychopharmacology Bulletin. 17: 51-4. PMID 7195052  0.503
1981 Valentino RJ, Smith CB, Woods JH. Physiological and behavioral approaches to the study of the quasi-morphine withdrawal syndrome. Federation Proceedings. 40: 1502-7. PMID 7194193  0.592
1981 Young AM, Swain HH, Woods JH. Comparison of opioid agonists in maintaining responding and in suppressing morphine withdrawal in rhesus monkeys. Psychopharmacology. 74: 329-35. PMID 6794076 DOI: 10.1007/BF00432741  0.795
1981 Herling S, Woods JH. Discriminative stimulus effects of etorphine in Rhesus monkeys. Psychopharmacology. 72: 265-267. PMID 6784144 DOI: 10.1007/Bf00431828  0.421
1981 Young AM, Katz JL, Woods JH. Behavioral effects of levonantradol and nantradol in the rhesus monkey. Journal of Clinical Pharmacology. 21: 348S-360S. PMID 6271836 DOI: 10.1002/J.1552-4604.1981.Tb02614.X  0.792
1981 Herling S, Woods JH. Iv. Discriminative Stimulus Effects Of Narcotics: Evidence For Multiple Receptor-Mediated Actions Life Sciences. 28: 1571-1584. PMID 6264253 DOI: 10.1016/0024-3205(81)90311-8  0.464
1981 Valentino RJ, Herling S, Woods JH, Medzihradsky F, Merz H. Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists. The Journal of Pharmacology and Experimental Therapeutics. 217: 652-9. PMID 6262493  0.577
1981 Woods JH, Herling S, Young AM. Comparison of discriminative and reinforcing stimulus characteristics of morphine-like opioids and two met-enkephalin analogues Neuropeptides. 1: 409-419. DOI: 10.1016/0143-4179(81)90039-1  0.784
1981 Herling S, Coale EH, Hein DW, Winger G, Woods JH. Similarity of the discriminative stimulus effects of ketamine, cyclazocine, and dextrorphan in the pigeon Psychopharmacology. 73: 286-291. DOI: 10.1007/BF00422419  0.34
1980 Herling S, Coale EH, Valentino RJ, Hein DW, Woods JH. Narcotic discrimination in pigeons. The Journal of Pharmacology and Experimental Therapeutics. 214: 139-46. PMID 6993656  0.444
1980 Abelson JS, Woods JH. Effects of apomorphine on elicited and operant pecking in pigeons. Psychopharmacology. 71: 237-241. PMID 6779332 DOI: 10.1007/Bf00433057  0.362
1980 Young AM, Woods JH. Behavior maintained by intravenous injection of codeine, cocaine, and etorphine in the rhesus macaque and the pigtail macaque. Psychopharmacology. 70: 263-71. PMID 6777798 DOI: 10.1007/BF00427883  0.794
1980 Moody DB, Winger G, Woods JH, Stebbins WC. Effect of ethanol and of noise on reaction time in the monkey: variation with stimulus level. Psychopharmacology. 69: 45-51. PMID 6771825 DOI: 10.1007/Bf00426520  0.303
1980 Woods JH. Narcotic-reinforced responding: A rapid evaluation procedure Drug and Alcohol Dependence. 5: 223-230. PMID 6766377 DOI: 10.1016/0376-8716(80)90182-9  0.352
1979 Valentino RJ, Smith CB, Woods JH. An unusual benzazocine elicits acetylcholine release in the isolated guinea pig ileum. Nature. 281: 370-2. PMID 225676 DOI: 10.1038/281370A0  0.619
1979 Woods JH, Herling S, Valentino RJ, Hein DW, Coale EH. Narcotic drug discriminations by rhesus monkeys and pigeons. Nida Research Monograph. 27: 128-34. PMID 121328  0.484
1979 Herling S, Downs DA, Woods JH. Cocaine, d-amphetamine, and pentobarbital effects on responding maintained by food or cocaine in rhesus monkeys Psychopharmacology. 64: 261-269. PMID 116268 DOI: 10.1007/BF00427508  0.445
1978 Tessel RE, Woods JH. meta Substituted N-ethylamphetamine self injection responding in the rhesus monkey: structure-activity relationships. The Journal of Pharmacology and Experimental Therapeutics. 205: 274-81. PMID 417172  0.599
1978 Tepper P, Woods JH. Changes in locomotor activity and naloxone-induced jumping in mice produced by WIN 35, 197-2 (ethylketazocine) and morphine. Psychopharmacology. 58: 125-129. PMID 98778 DOI: 10.1007/Bf00426894  0.51
1978 Karoly AJ, Winger G, Ikomi F, Woods JH. The reinforcing property of ethanol in the rhesus monkey - II. Some variables related to the maintenance of intravenous ethanol-reinforced responding Psychopharmacology. 58: 19-25. PMID 97716 DOI: 10.1007/Bf00426785  0.305
1976 Carney JM, Llewellyn ME, Woods JH. Variable interval responding maintained by intravenous codeine and ethanol injections in the rhesus monkey. Pharmacology, Biochemistry, and Behavior. 5: 577-52. PMID 828270 DOI: 10.1016/0091-3057(76)90272-0  0.359
1976 Llewellyn ME, Iglauer C, Woods JH. Relative reinforcer magnitude under a nonindependent concurrent schedule of cocaine reinforcement in rhesus monkeys. Journal of the Experimental Analysis of Behavior. 25: 81-91. PMID 814191 DOI: 10.1901/jeab.1976.25-81  0.418
1975 Downs DA, Woods JH. Fixed ratio escape and avoidance escape from naloxone in morphine dependent monkeys: effects of naloxone dose and morphine pretreatment Journal of the Experimental Analysis of Behavior. 23: 415-427. PMID 1170272 DOI: 10.1901/Jeab.1975.23-415  0.426
1975 Downs DA, Woods JH. Food- and drug-reinforced responding: Effects of DITA and d-amphetamine Psychopharmacologia. 43: 13-17. PMID 1161990 DOI: 10.1007/BF00437608  0.368
1975 Tessel RE, Woods JH, Counsell RE, Basmadjian GP. Structure-activity relationships between meta-substituted N-ethylamphetamines and isolated guinea-pig atrial rate. The Journal of Pharmacology and Experimental Therapeutics. 192: 319-26. PMID 1117419  0.616
1975 Tessel RE, Woods JH, Counsell RE, Lu M. Structure-activity relationships between meta-substituted N-ethylamphetamines and locomotor activity in mice. The Journal of Pharmacology and Experimental Therapeutics. 192: 310-8. PMID 1117418  0.644
1975 Winger G, Stitzer ML, Woods JH. Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action. The Journal of Pharmacology and Experimental Therapeutics. 195: 505-14. PMID 811787  0.516
1975 Tessel RE, Woods JH. Fenfluramine and N-ethyl amphetamine: comparison of the reinforcing and rate-decreasing actions in the rhesus monkey. Psychopharmacologia. 43: 239-44. PMID 810821 DOI: 10.1007/BF00429257  0.696
1975 Rosenberg J, Woods JH. Effects of pentobarbital on fixed-ratio discrimination* Bulletin of the Psychonomic Society. 5: 33-35. DOI: 10.3758/Bf03336692  0.348
1974 Iglauer C, Woods JH. Concurrent performances: reinforcement by different doses of intravenous cocaine in rhesus monkeys. Journal of the Experimental Analysis of Behavior. 22: 179-196. PMID 4455758 DOI: 10.1901/Jeab.1974.22-179  0.415
1974 Woods JH, Tessel RE. Fenfluramine: amphetamine congener that fails to maintain drug-taking behavior in the rhesus monkey. Science (New York, N.Y.). 185: 1067-9. PMID 4212011 DOI: 10.1126/Science.185.4156.1067  0.702
1971 Goldberg SR, Woods JH, Schuster CR. Nalorphine-induced changes in morphine self-administration in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 176: 464-71. PMID 4998693  0.542
1969 Goldberg SR, Woods JH, Schuster CR. Morphine: conditioned increases in self-administration in rhesus monkeys. Science (New York, N.Y.). 166: 1306-7. PMID 4981723 DOI: 10.1126/Science.166.3910.1306  0.634
1968 Woods JH, Schuster CR. Reinforcement Properties of Morphine, Cocaine, and SPA as a Function of Unit Dose International Journal of the Addictions. 3: 231-237. DOI: 10.3109/10826086809042898  0.645
1968 Schuster CR, Woods JH. The Conditioned Reinforcing Effects of Stimuli Associated with Morphine Reinforcement International Journal of the Addictions. 3: 223-230. DOI: 10.3109/10826086809042897  0.578
1966 Schuster CR, Dockens WS, Woods JH. Behavioral variables affecting the development of amphetamine tolerance. Psychopharmacologia. 9: 170-82. PMID 5983915 DOI: 10.1007/Bf00404721  0.6
1966 Schuster CR, Woods JH. Schedule-induced polydipsia in the rhesus monkey. Psychological Reports. 19: 823-8. PMID 4963005 DOI: 10.2466/pr0.1966.19.3.823  0.507
Show low-probability matches.